Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.

Primer3 on the WWW for General Users and for Biologist Programmers

Rozen, S., & Skaletsky, H. (2003) · Humana Press eBooks · doi:10.1385/1-59259-192-2:365 · Cited by 14,952 · see citing works

Integrated genomic analyses of ovarian carcinoma

Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,927 · see citing works

dbSNP: the NCBI database of genetic variation

Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502 · see citing works

Base-Calling of Automated Sequencer Traces Using Phred. I. Accuracy AssessmentPreprint

Ewing, B., Hillier, L., Wendl, M. C., & Green, P. (1998) · Genome Research · doi:10.1101/gr.8.3.175 · Cited by 6,993 · see citing works

Base-Calling of Automated Sequencer Traces Using <i>Phred.</i> II. Error Probabilities

Ewing, B., & Green, P. (1998) · Genome Research · doi:10.1101/gr.8.3.186 · Cited by 5,439 · see citing works

Cancer genes and the pathways they control

Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,245 · see citing works

Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium

Pecorelli, S. (2009) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.02.012 · Cited by 2,888 · see citing works

Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis

Bristow, R. E., Tomacruz, R. S., Armstrong, D. K., Trimble, E. L., & Montz, F. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.5.1248 · Cited by 2,316 · see citing works

A Population-Based Study

Christakis, D., Richards, J. A., Zimmerman, F. J., Garrison, M. M., Xu, D., & Yapanel, U. H. (2009) · Cited by 2,290 · see citing works

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq929 · Cited by 2,278 · see citing works

Global estimates of cancer prevalence for 27 sites in the adult population in 2008

Bray, F., Ren, J., Masuyer, E., & Ferlay, J. (2012) · International Journal of Cancer · doi:10.1002/ijc.27711 · Cited by 1,893 · see citing works

Effect of Screening on Ovarian Cancer Mortality

Buys, S. S. (2011) · JAMA · doi:10.1001/jama.2011.766 · Cited by 1,326 · see citing works

Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma

Jones, S., Wang, T., Shih, I., Mao, T., Nakayama, K., Roden, R. B. S., Glas, R., Slamon, D. J., Diaz, L. A., Vogelstein, B., et al. (2010) · Science · doi:10.1126/science.1196333 · Cited by 1,218 · see citing works

Detection and quantification of rare mutations with massively parallel sequencing

Kinde, I., Wu, J., Papadopoulos, N., Kinzler, K. W., & Vogelstein, B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105422108 · Cited by 1,205 · see citing works

Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer

Mayrand, M., Duarte‐Franco, E., Rodrigues, I., Walter, S. D., Hanley, J. A., Ferenczy, A. S., Ratnam, S., Coutlée, F., & Franco, E. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071430 · Cited by 1,106 · see citing works

Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer

Nauclér, P., Ryd, W., Törnberg, S., Strand, A., Wadell, G., Elfgren, K., Rådberg, T., Strander, B., Johansson, B., Forslund, O., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073204 · Cited by 797 · see citing works

Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development

Wu, J., Matthaei, H., Maitra, A., Molin, M. D., Wood, L., Eshleman, J., Goggins, M., Canto, M., Schulick, R., Edil, B., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002543 · Cited by 786 · see citing works

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document

Arbyn, M., Anttila, A., Jordan, J. A., Ronco, G., Schenck, U., Segnan, N., Wiener, H., Herbert, A., & von Karsa, L. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp471 · Cited by 762 · see citing works

Grading Ovarian Serous Carcinoma Using a Two-Tier System

Malpica, A. L., Deavers, M. T., Lu, K. H., Bodurka, D. C., Atkinson, E. N., Gershenson, D. M., & Silva, E. G. (2004) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200404000-00009 · Cited by 671 · see citing works

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers

Hamilton, C. A., Cheung, M. K., Osann, K., Chen, L., Teng, N. N. H., Longacre, T. A., Powell, M. A., Hendrickson, M. R., Kapp, D. S., & Chan, J. K. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603012 · Cited by 647 · see citing works

Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.

Lindor, N. M., Petersen, G. M., Hadley, D. W., Kinney, A. Y., Miesfeldt, S., Lu, K. H., Lynch, P. M., Burke, W., & Press, N. A. (2006) · PubMed · doi:10.1001/jama.296.12.1507 · Cited by 628 · see citing works

High Frequency of Coexistent Mutations of PIK3CA and PTEN Genes in Endometrial Carcinoma

Oda, K., Stokoe, D., Taketani, Y., & McCormick, F. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2620 · Cited by 467 · see citing works

Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: A systematic review

Gunderson, C. C., Fader, A. N., Carson, K. A., & Bristow, R. E. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.01.003 · Cited by 462 · see citing works

Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations

Barrow, E., Robinson, L. A., Alduaij, W., Shenton, A., Clancy, T., Lalloo, F. I., Hill, J., & Evans, D. G. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01125.x · Cited by 318 · see citing works

Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens

Cramer, D. W., Bast, R. C., Berg, C. D., Diamandis, E. P., Godwin, A. K., Hartge, P. A., Lokshin, A. E., Lu, K. H., McIntosh, M. W., Mor, G., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0195 · Cited by 300 · see citing works

Issues in data monitoring and interim analysis of trials

Grant, A., Altman, D. G., Babiker, A. G., Campbell, M., Clemens, F., Darbyshire, J. H., Elbourne, D. R., McLeer, S., Parmar, M., Pocock, S., et al. (2005) · Health Technology Assessment · doi:10.3310/hta9070 · Cited by 272 · see citing works

Diagnoses and outcomes in cervical cancer screening: A population-based study

Insinga, R. P., Glass, A. G., & Rush, B. B. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.01.043 · Cited by 261 · see citing works

Results From Four Rounds of Ovarian Cancer Screening in a Randomized Trial

Partridge, E. E., Kreimer, A. R., Greenlee, R. T., Williams, C., Xu, J.-L., Church, T. R., Kessel, B., Johnson, C. C., Weissfeld, J. L., Isaacs, C. J., et al. (2009) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31819cda77 · Cited by 258 · see citing works

Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses

Kuhn, E., Wu, R., Guan, B., Wu, G., Zhang, J., Wang, Y., Song, L., Yuan, X., Wei, L., Roden, R. B. S., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs345 · Cited by 249 · see citing works

Low‐grade serous carcinomas of the ovary contain very few point mutations

Jones, S., Wang, T., Kurman, R. J., Nakayama, K., Velculescu, V. E., Vogelstein, B., Kinzler, K. W., Papadopoulos, N., & Shih, I. (2011) · The Journal of Pathology · doi:10.1002/path.3967 · Cited by 219 · see citing works

Serial Assessment of Human Tumor Burdens in Mice by the Analysis of Circulating DNA

Rago, C., Huso, D. L., Diehl, F., Karim, B. O., Liu, G., Papadopoulos, N., Samuels, Y., Velculescu, V. E., Vogelstein, B., Kinzler, K. W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0605 · Cited by 163 · see citing works

Screening for Ovarian Cancer

Carlson, K. J., Skates, S. J., & Singer, D. E. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-2-199407150-00009 · Cited by 147 · see citing works

Integrated genomic analyses of ovarian carcinoma

The Cancer Genome Atlas Research Network (2011) · Nature · doi:10.1038/nature10166 · Cited by 129 · see citing works

CA 125 in Benign Gynecological Conditions

Meden, H., & Fattahi-Meibodi, A. (1998) · The International Journal of Biological Markers · doi:10.1177/172460089801300411 · Cited by 126 · see citing works

Transvaginal Ultrasound for Identifying Endometrial Abnormality

Smith, P., Bakos, O., Heimer, G. M., & Ulmsten, U. (1991) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016349109007922 · Cited by 116 · see citing works

Screening for Ovarian Cancer: Recommendation Statement

U.S. Preventive Services Task Force (2004) · The Annals of Family Medicine · doi:10.1370/afm.200 · Cited by 104 · see citing works

Cervical screening programmes: can automation help? Evidence from systematic reviews, an economic analysis and a simulation modelling exercise applied to the UK

Willis, B. H., Barton, P. M., Pearmain, P., Bryan, S., & Hyde, C. (2005) · Health Technology Assessment · doi:10.3310/hta9130 · Cited by 94 · see citing works

Dysplasia Associated With Atypical Glandular Cells on Cervical Cytology

Sharpless, K. E., Schnatz, P. F., Mandavilli, S. R., Greene, J. F., & Sorosky, J. I. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000152350.10875.02 · Cited by 84 · see citing works

ACOG Committee Opinion Number 280: The Role of the Generalist Obstetrician-Gynecologist in the Early Detection of Ovarian Cancer

Committee on Gynecologic Practice, S. O. G. O. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02630-3 · Cited by 71 · see citing works

Rate of Pathology From Atypical Glandular Cell Pap Tests Classified by the Bethesda 2001 Nomenclature

DeSimone, C. P., Day, M. E., Tovar, M. M., Dietrich, C. S., Eastham, M. L., & Modesitt, S. C. (2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000218705.87329.4a · Cited by 67 · see citing works

IgH gene rearrangements as plasma biomarkers in Non-Hodgkin's Lymphoma patients

He, J., Wu, J., Jiao, Y., Wagner‐Johnston, N. D., Ambinder, R. F., Diaz, L. A., Kinzler, K. W., Vogelstein, B., & Papadopoulos, N. (2011) · Oncotarget · doi:10.18632/oncotarget.235 · Cited by 66 · see citing works

Clinical evaluation of atypical glandular cells of undetermined significance

Geier, C. S., Wilson, M. E., & Creasman, W. T. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.108995 · Cited by 61 · see citing works

Survival benefit for patients with advanced-stage transitional cell carcinomas vs. other subtypes of ovarian carcinoma after chemotherapy with platinum and paclitaxel

Kommoss, F., Kommoss, S., Schmidt, D., Trunk, M. J., Pfisterer, J., & du Bois, A. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.12.047 · Cited by 60 · see citing works

Endometrial sampling techniques in the diagnosis of abnormal uterine bleeding

Cooper, J. M., & Erickson, M. L. (2000) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(00)80018-2 · Cited by 50 · see citing works

Accuracy and Survival Benefit of Cytological Prediction of Endometrial Carcinoma on Routine Cervical Smears

Mitchell, H., Giles, G. G., & Medley, G. (1993) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199301000-00005 · Cited by 44 · see citing works

Liquid-Based Papanicolaou Tests in Endometrial Carcinoma Diagnosis

Sams, S. B., Currens, H. S., & Raab, S. S. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcplfbk1a2xjdqi · Cited by 39 · see citing works

Cancer of the Uterus: The Vaginal Smear in Its Diagnosis.

Traut, H. F., & Papanicolaou, G. N. (1943) · PubMed · Cited by 37 · see citing works

Células glandulares atípicas e câncer de colo uterino: revisão sistemática

Marques, J. P. D. H., Costa, L. B., Pinto, A. P. D. S. E., de Lima, A. F., Duarte, M. E. L., Barbosa, A. P. F., & de Medeiros, P. L. (2011) · Revista da Associação Médica Brasileira · doi:10.1590/s0104-42302011000200024 · Cited by 35 · see citing works

Transitional Cell Carcinoma of the Ovary

Lin, C., Liu, F.-S., & Ho, E. S. (2006) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/s1028-4559(09)60240-0 · Cited by 31 · see citing works

Atypical glandular cells and cervical cancer: systematic review

Marques, J. P. D. H., Costa, L. B., Pinto, A. P. D. S. E., de Lima, A. F., Duarte, M. E. L., Barbosa, A. P. F., & de Medeiros, P. L. (2011) · Revista da Associação Médica Brasileira (English Edition) · doi:10.1016/s2255-4823(11)70049-2 · Cited by 30 · see citing works

Practical Principles of Cytopathology

DeMay, R. M. (1999) · Cited by 27 · see citing works

Screening for ovarian cancer: recommendation statement. U.S. Preventive Services Task Force.

(2005) · PubMed · Cited by 26 · see citing works

Transitional cell carcinoma of the ovary (Review)

Ichigo, S., Takagi, H., Matsunami, K., MURASE, T., Ikeda, T., & Imai, A. (2011) · Oncology Letters · doi:10.3892/ol.2011.453 · Cited by 22 · see citing works

Screening for Ovarian Cancer: Recommendation Statement

The University of North Carolina at Chapel Hill University Libraries (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/qxrq-ms42 · Cited by 3 · see citing works

Liquid biopsies come of age: Towards implementation of circulating tumour DNA

Wan, J. C. M., Massie, C., Garcia-Corbacho, J., Mouliere, F., Brenton, J. D., Caldas, C., Pacey, S., Baird, R., & Rosenfeld, N. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.7 · Cited by 2,809 · see citing works

A view on drug resistance in cancer

Vasan, N., Baselga, J., & Hyman, D. M. (2019) · Nature · doi:10.1038/s41586-019-1730-1 · Cited by 2,770 · see citing works

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

Tie, J., Wang, Y., Tomasetti, C., Li, L., Springer, S., Kinde, I., Silliman, N., Tacey, M., Wong, H.-L., Christie, M., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6219 · Cited by 1,492 · see citing works

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

Bowtell, D. D. L., Böhm, S., Ahmed, A. A., Aspuria, P.-J. P., Bast, R. C., Beral, V., Berek, J. S., Birrer, M. J., Blagden, S. P., Bookman, M. A., et al. (2015) · Nature reviews. Cancer · doi:10.1038/nrc4019 · Cited by 1,365 · see citing works

Tumour heterogeneity in the clinic

Bedard, P. L., Hansen, A. R., Ratain, M. J., & Siu, L. L. (2013) · Nature · doi:10.1038/nature12627 · Cited by 1,205 · see citing works

The Next-Generation Sequencing Revolution and Its Impact on Genomics

Koboldt, D. C., Steinberg, K. M., Larson, D. E., Wilson, R. K., & Mardis, E. R. (2013) · Cell · doi:10.1016/j.cell.2013.09.006 · Cited by 1,039 · see citing works

The Dualistic Model of Ovarian Carcinogenesis

Kurman, R. J., & Shih, I. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.11.011 · Cited by 933 · see citing works

High grade serous ovarian carcinomas originate in the fallopian tube

Labidi‐Galy, S. I., Papp, E., Hallberg, D. L., Niknafs, N., Adleff, V., Noë, M., Bhattacharya, R., Novak, M., Jones, S., Phallen, J. A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00962-1 · Cited by 762 · see citing works

Classification of endometrial carcinoma: more than two types

Murali, R., Soslow, R. A., & Weigelt, B. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70591-6 · Cited by 649 · see citing works

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer

Tie, J., Kinde, I., Wang, Y., Wong, H., Roebert, J. K., Christie, M., TACEY, M. A., Wong, R., Singh, M., Karapetis, C. S., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv177 · Cited by 632 · see citing works

Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers

Cohen, J. D., Javed, A. A., Thoburn, C. J., Wong, F., Tie, J., Gibbs, P., Schmidt, C. M., Yip-Schneider, M., Allen, P. J., Schattner, M. A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704961114 · Cited by 581 · see citing works

The emerging role of cell-free DNA as a molecular marker for cancer management

Bronkhorst, A. J., Ungerer, V., & Holdenrieder, S. (2019) · Biomolecular Detection and Quantification · doi:10.1016/j.bdq.2019.100087 · Cited by 566 · see citing works

Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations

Salk, J. J., Schmitt, M. W., & Loeb, L. A. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.117 · Cited by 536 · see citing works

Studying clonal dynamics in response to cancer therapy using high-complexity barcoding

Bhang, H.-E. C., Ruddy, D. A., Krishnamurthy Radhakrishna, V., Caushi, J. X., Zhao, R., Hims, M. M., Singh, A. P., Kao, I., Rakiec, D., Shaw, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3841 · Cited by 507 · see citing works

Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas

Wang, Y., Springer, S. U., Jenks, C. M., Silliman, N., Schaefer, J., Sausen, M., James, N., Rettig, E. M., Guo, T. W., Pickering, C. R., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa8507 · Cited by 503 · see citing works

A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts

Springer, S., Wang, Y., Dal Molin, M., Masica, D. L., Jiao, Y., Kinde, I., Blackford, A., Raman, S. P., Wolfgang, C. L., Tomita, T., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.041 · Cited by 477 · see citing works

Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord

Wang, Y., Springer, S. U., Zhang, M., McMahon, K. W., Kinde, I., Dobbyn, L., Ptak, J., Brem, H., Chaichana, K. L., Gallia, G. L., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511694112 · Cited by 455 · see citing works

Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women

Clarke, M. A., Long, B. J., Del Mar Morillo, A., Arbyn, M., Bakkum-Gamez, J. N., & Wentzensen, N. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.2820 · Cited by 426 · see citing works

Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma

Jiang, X., Hao, H.-X., Growney, J. D., Woolfenden, S., Bottiglio, C., Ng, N., Lu, B., Hsieh, M. H., Bagdasarian, L., Meyer, R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307218110 · Cited by 415 · see citing works

Clinical actionability of molecular targets in endometrial cancer

Urick, M. E., & Bell, D. W. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0177-x · Cited by 405 · see citing works

Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer

Roberts, N. J., Norris, A. L., Petersen, G. M., Bondy, M. L., Brand, R., Gallinger, S., Kurtz, R. C., Olson, S. H., Rustgi, A. K., Schwartz, A. G., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0402 · Cited by 361 · see citing works

Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis

Weaver, J. M. J., Ross-Innes, C. S., Shannon, N. B., Lynch, A. G., Forshew, T., Barbera, M., Murtaza, M., Ong, C. J., Lao-Sirieix, P., Dunning, M., et al. (2014) · Nature Genetics · doi:10.1038/ng.3013 · Cited by 348 · see citing works

Origin and molecular pathogenesis of ovarian high-grade serous carcinoma

Kurman, R. J. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt463 · Cited by 335 · see citing works

Early Detection of Cancer: Past, Present, and Future

Schiffman, J. D., Fisher, P. G., & Gibbs, P. (2015) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2015.35.57 · Cited by 352 · see citing works

Molecular Genetics of Endometrial Carcinoma

Bell, D. W., & Ellenson, L. H. (2018) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043609 · Cited by 299 · see citing works

Brain Tumor Mutations Detected in Cerebral Spinal Fluid

Pan, W., Gu, W., Nagpal, S., Gephart, M. H., & Quake, S. R. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.235457 · Cited by 296 · see citing works

The role of the fallopian tube in the origin of ovarian cancer

Erickson, B. K., Conner, M., & Landen, C. N. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.04.019 · Cited by 289 · see citing works

Ovarian Cancer Prevention and Screening

Menon, U., Karpinskyj, C., & Gentry‐Maharaj, A. (2018) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002580 · Cited by 281 · see citing works

The Origin of Ovarian Cancer Species and Precancerous Landscape

Shih, I., Wang, Y., & Wang, T. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.09.006 · Cited by 255 · see citing works

<i>TERT</i> Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine

Kinde, I., Munari, E., Faraj, S. F., Hruban, R. H., Schoenberg, M., Bivalacqua, T., Allaf, M., Springer, S., Wang, Y., Diaz, L. A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2498 · Cited by 253 · see citing works

Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers

Wang, Y., Li, L., Douville, C. B., Cohen, J. D., Yen, T., Kinde, I., Sundfelt, K., Kjær, S. K., Hruban, R. H., Shih, I., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aap8793 · Cited by 245 · see citing works

Circulating Tumor DNA as Biomarkers for Cancer Detection

Han, X., Wang, J., & Sun, Y. (2017) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.12.004 · Cited by 241 · see citing works

Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma

Ducie, J. A., Dao, F., Considine, M., Olvera, N., Shaw, P. A., Kurman, R. J., Shih, I., Soslow, R. A., Cope, L., & Levine, D. A. (2017) · Nature Communications · doi:10.1038/s41467-017-01217-9 · Cited by 225 · see citing works

Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencing

Hoang, M. L., Kinde, I., Tomasetti, C., McMahon, K. W., Rosenquist, T. A., Grollman, A. P., Kinzler, K. W., Vogelstein, B., & Papadopoulos, N. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607794113 · Cited by 224 · see citing works

A multimodality test to guide the management of patients with a pancreatic cyst

Springer, S., Masica, D. L., Dal Molin, M., Douville, C., Thoburn, C. J., Afsari, B., Li, L., Cohen, J. D., Thompson, E., Allen, P. J., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav4772 · Cited by 217 · see citing works

Do Circulating Tumor Cells, Exosomes, and Circulating Tumor Nucleic Acids Have Clinical Utility?

Gold, B., Cankovic, M., Furtado, L. V., Meier, F. A., & Gocke, C. D. (2015) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.02.001 · Cited by 205 · see citing works

Prophylactic HPV vaccination: past, present, and future

Castle, P. E., & Maza, M. (2015) · Epidemiology and Infection · doi:10.1017/s0950268815002198 · Cited by 201 · see citing works

Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline

Jerónimo, J., Castle, P. E., Temin, S., Denny, L., Gupta, V., Kim, J. J., Luciani, S., Murokora, D., Ngoma, T. A., Qiao, Y., et al. (2016) · Journal of Global Oncology · doi:10.1200/jgo.2016.006577 · Cited by 204 · see citing works

The RING finger protein family in health and disease

Cai, C., Tang, Y., Zhai, J., & Zheng, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01152-2 · Cited by 194 · see citing works

Origin and Pathogenesis of Pelvic (Ovarian, Tubal, and Primary Peritoneal) Serous Carcinoma

Nasseri-Nik, N., VANG, R. S., Shih, I., & Kurman, R. J. (2013) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163949 · Cited by 173 · see citing works

Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma

VANG, R. S., Levine, D. A., Soslow, R. A., Zaloudek, C. J., Shih, I., & Kurman, R. J. (2015) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000207 · Cited by 171 · see citing works

The potential of liquid biopsies for the early detection of cancer

Heitzer, E., Perakis, S. O., Geigl, J. B., & Speicher, M. R. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0039-5 · Cited by 166 · see citing works

Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review

Liberto, J. M., Chen, S.-Y., Shih, I., Wang, T., Wang, T., & Pisanic, T. R. (2022) · Cancers · doi:10.3390/cancers14122885 · Cited by 170 · see citing works

Potential clinical utility of liquid biopsies in ovarian cancer

Zhu, J. W., Charkhchi, P., & Akbari, M. R. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01588-8 · Cited by 161 · see citing works

Molecular Classification and Emerging Targeted Therapy in Endometrial Cancer

Yen, T., Wang, T., Fader, A. N., Shih, I., & Gaillard, S. L. (2019) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000585 · Cited by 163 · see citing works

Ovarian cancer screening—Current status, future directions

Menon, U., Griffin, M., & Gentry‐Maharaj, A. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.11.030 · Cited by 156 · see citing works

Ultra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissues

Krimmel‐Morrison, J. D., Schmitt, M. W., Harrell, M. I., Agnew, K. J., Kennedy, S. R., Emond, M. J., Loeb, L. A., Swisher, E. M., & Risques, R. A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601311113 · Cited by 155 · see citing works

TP53 mutations in epithelial ovarian cancer

Zhang, Y., Cao, L., Nguyen, D., & Lu, H. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.08.40 · Cited by 149 · see citing works

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials

Skates, S. J., Greene, M. H., Buys, S. S., Mai, P. L., Brown, P. H., Piedmonte, M., Rodriguez, G. C., Schorge, J. O., Sherman, M. E., Daly, M. B., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2750 · Cited by 140 · see citing works

Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations

Castro-Giner, F., Gkountela, S., Donato, C., Alborelli, I., Quagliata, L., Ng, C. K. Y., Piscuoglio, S., & Aceto, N. (2018) · Diagnostics · doi:10.3390/diagnostics8020031 · Cited by 138 · see citing works

Ovarian cancer screening: Current status and future directions

Nash, Z., & Menon, U. (2020) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2020.02.010 · Cited by 139 · see citing works

The primate vaginal microbiome: Comparative context and implications for human health and disease

Stumpf, R. M., Wilson, B. A., Rivera, A. J., Yıldırım, S., Yeoman, C. J., Polk, J. D., White, B. A., & Leigh, S. R. (2013) · American Journal of Physical Anthropology · doi:10.1002/ajpa.22395 · Cited by 132 · see citing works

Novel Approaches to Ovarian Cancer Screening

Nebgen, D. R., Lu, K. H., & Bast, R. C. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0816-0 · Cited by 132 · see citing works

The role of biomarkers in the management of epithelial ovarian cancer

Yang, W., Lü, Z., & Bast, R. C. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1326820 · Cited by 130 · see citing works

The value of cell‐free DNA for molecular pathology

Stewart, C. M., Kothari, P. D., Mouliere, F. C., Mair, R. J., Somnay, S., Benayed, R., Zehir, A., Weigelt, B., Dawson, S., Arcila, M. E., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5048 · Cited by 125 · see citing works

Diagnosis of ovarian cancer

Sundar, S. S., Neal, R. D., & Kehoe, S. T. (2015) · BMJ · doi:10.1136/bmj.h4443 · Cited by 120 · see citing works

Screening for ovarian cancer: imaging challenges and opportunities for improvement

Mathieu, K. B., Bedi, D. G., Thrower, S. L., Qayyum, A., & Bast, R. C. (2017) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.17557 · Cited by 118 · see citing works

Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study

Maritschnegg, E., Wang, Y., Pecha, N., Horvat, R., Nieuwenhuysen, E. V., Vergote, I. B., Heitz, F., Sehouli, J., Kinde, I., Diaz, L. A., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.3083 · Cited by 114 · see citing works

Targeting Wnts at the Source—New Mechanisms, New Biomarkers, New Drugs

Madan, B., & Virshup, D. M. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-1038 · Cited by 112 · see citing works

Next-Generation Sequencing and Fluorescence in Situ Hybridization Have Comparable Performance Characteristics in the Analysis of Pancreaticobiliary Brushings for Malignancy

Dudley, J. C., Zheng, Z., McDonald, T. O., Le, L. P., Dias-Santagata, D. C., Borger, D. R., Batten, J. M., Vernovsky, K., Sweeney, B. J., Arpin, R., et al. (2015) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.08.002 · Cited by 109 · see citing works

Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons.

Bakkum-Gamez, J. N., Wentzensen, N., Maurer, M. J., Hawthorne, K. M., Voss, J. S., Kroneman, T. N., Famuyide, A. O., Clayton, A. C., Halling, K. C., Kerr, S. E., et al. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.01.552 · Cited by 107 · see citing works

Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA

Semenkovich, N. P., Szymanski, J. J., Earland, N. J., Chauhan, P. S., Pellini, B., & Chaudhuri, A. A. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006284 · Cited by 108 · see citing works

Integrated Epigenomics Analysis Reveals a DNA Methylation Panel for Endometrial Cancer Detection Using Cervical Scrapings

Huang, R., Su, P., Liao, Y.-P., Wu, T.-I., Hsu, Y., Lin, W., Wang, H.-C., Weng, Y., Ou, Y., Huang, T. H. ‐., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0863 · Cited by 104 · see citing works

Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan

Salk, J. J., Loubet-Senear, K. J., Maritschnegg, E., Valentine, C. C., Williams, L. N., Higgins, J. E., Horvat, R., Vanderstichele, A., Nachmanson, D., Baker, K. T., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.109 · Cited by 98 · see citing works

Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study

Nair, N., Camacho‐Vanegas, O., Rykunov, D., Dashkoff, M., Camacho, S. C., Schumacher, C. A., Irish, J. C., Harkins, T. T., Freeman, E., Garcia, I., et al. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002206 · Cited by 100 · see citing works

New perspectives on screening and early detection of endometrial cancer

Costas, L., Frias‐Gomez, J., Guardiola, M., Benavente, Y., Pineda, M., Pavón, M. Á., Martínez, J. M., Climent, M., Barahona, M., Canet, J., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32514 · Cited by 100 · see citing works

Biophysicochemical Motifs in T-cell Receptor Sequences Distinguish Repertoires from Tumor-Infiltrating Lymphocyte and Adjacent Healthy Tissue

Ostmeyer, J., Christley, S., Toby, I. T., & Cowell, L. G. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2292 · Cited by 98 · see citing works

CADM1 , MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer

Strooper, L. M. A. D., van Zummeren, M., Steenbergen, R. D. M., Bleeker, M. C. G., Hesselink, A. T., Wisman, G. B. A., Snijders, P. J. F., Heideman, D. A. M., & Meijer, C. J. L. M. (2014) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202616 · Cited by 98 · see citing works

Preanalytical variables that affect the outcome of cell-free DNA measurements

Ungerer, V., Bronkhorst, A. J., & Holdenrieder, S. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1750558 · Cited by 96 · see citing works

The Emerging Genomic Landscape of Endometrial Cancer

Gallo, M. L., & Bell, D. W. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.205740 · Cited by 95 · see citing works

Challenges and opportunities of next‐generation sequencing: a cytopathologist's perspective

Vigliar, E., Malapelle, U., Luca, C. D., Bellevicine, C., & Troncone, G. (2015) · Cytopathology · doi:10.1111/cyt.12265 · Cited by 91 · see citing works

High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma

Stelloo, E., Nout, R. A., Naves, L. C. L. M., ter Haar, N. T., Creutzberg, C. L., Smit, V. T. H. B. M., & Bosse, T. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.02.012 · Cited by 90 · see citing works

Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences

Felix, A. S., Yang, H., Bell, D. W., & Sherman, M. E. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-43139-0_1 · Cited by 90 · see citing works

Proteomic Biomarkers for the Detection of Endometrial Cancer

Njoku, K., Chiasserini, D., Whetton, A. D., & Crosbie, E. J. (2019) · Cancers · doi:10.3390/cancers11101572 · Cited by 87 · see citing works

Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets—a narrative review

Samartzis, E. P., Labidi‐Galy, S. I., Moschetta, M., Uccello, M., Kalaitzopoulos, D. R., Fidalgo, J. A. P., & Boussios, S. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-3022a · Cited by 82 · see citing works

Current and future approaches to screening for endometrial cancer

Gentry‐Maharaj, A., & Karpinskyj, C. (2020) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2019.12.006 · Cited by 84 · see citing works

Somatic Host Cell Alterations in HPV Carcinogenesis

Litwin, T. R., Clarke, M. A., Dean, M. C., & Wentzensen, N. (2017) · Viruses · doi:10.3390/v9080206 · Cited by 83 · see citing works

Loss of Connectivity in Cancer Co-Expression Networks

Anglani, R., Creanza, T. M., Liuzzi, V. C., Piepoli, A., Panza, A., Andriulli, A., & Ancona, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087075 · Cited by 79 · see citing works

Discovery and validation of methylation markers for endometrial cancer

Wentzensen, N., Bakkum-Gamez, J. N., Killian, J. K., Sampson, J. N., Guido, R. S., Glass, A. G., Adams, L. G., Luhn, P., Brinton, L. A., Rush, B. B., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28843 · Cited by 77 · see citing works

Minimally invasive approaches for the early detection of endometrial cancer

Shen, Y., Yang, W., Liu, J., & Zhang, Y. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01757-3 · Cited by 76 · see citing works

Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing

Gallo, M. L., Rudd, M. L., Urick, M. E., Hansen, N. F., Zhang, S., Program, N. C. S., Lozy, F., Sgroi, D. C., Vidal, A., Matías‐Guiu, X., et al. (2017) · Cancer · doi:10.1002/cncr.30745 · Cited by 75 · see citing works

Cancer Cytosensing Approaches in Miniaturized Settings Based on Advanced Nanomaterials and Biosensors

Purohit, B., Kumar, A., Mahato, K., Roy, S., & Chandra, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-818823-1.00009-0 · Cited by 75 · see citing works

In vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells

Yamamoto, Y., Ning, G., Howitt, B. E., Mehra, K. K., Wu, L., Wang, X., Yue, H., Kern, F., Wei, T. S., Zhang, T., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4649 · Cited by 75 · see citing works

New Perspectives on the Importance of Cell-Free DNA Biology

Bronkhorst, A. J., Ungerer, V., Oberhofer, A., Gabriel, S., Polatoglou, E., Randeu, H., Uhlig, C., Pfister, H., Mayer, Z., & Holdenrieder, S. (2022) · Diagnostics · doi:10.3390/diagnostics12092147 · Cited by 77 · see citing works

Clinical Utility of Cell-free and Circulating Tumor DNA in Kidney and Bladder Cancer: A Critical Review of Current Literature

Green, E. A., Li, R., Albiges, L. K., Choueiri, T. K., Freedman, M. L., Pal, S. K., Dyrskjøt, L., & Kamat, A. M. (2021) · European Urology Oncology · doi:10.1016/j.euo.2021.04.005 · Cited by 73 · see citing works

Targeted single molecule mutation detection with massively parallel sequencing

Gregory, M., Bertout, J. A., Ericson, N. G., Taylor, S. D., Mukherjee, R., Robins, H. S., Drescher, C. W., & Bielas, J. H. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv915 · Cited by 69 · see citing works

Systematic transcriptome analysis reveals tumor-specific isoforms for ovarian cancer diagnosis and therapy

Barrett, C. L., DeBoever, C., Jepsen, K., Saenz, C. C., Carson, D. A., & Frazer, K. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508057112 · Cited by 68 · see citing works

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer

Chen, Q., Zhang, Z., Wang, S., & Lang, J. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s227156 · Cited by 66 · see citing works

Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma

Eich, M., Peña, M. D. C. R., Springer, S. U., Taheri, D., Tregnago, A. C., Salles, D. C., Bezerra, S. M., da Cunha, I. W., Fujita, K., Ertoy, D., et al. (2019) · Modern Pathology · doi:10.1038/s41379-019-0276-y · Cited by 62 · see citing works

Liquid biopsy in ovarian cancer: Catching the silent killer before it strikes

Feeney, L., Harley, I. J. G., McCluggage, W. G., Mullan, P. B., & Beirne, J. (2020) · World Journal of Clinical Oncology · doi:10.5306/wjco.v11.i11.868 · Cited by 59 · see citing works

Tumor DNA: an emerging biomarker in head and neck cancer

Bellairs, J. A., Hasina, R., & Agrawal, N. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9685-x · Cited by 60 · see citing works

Ascites analysis by a microfluidic chip allows tumor-cell profiling

Peterson, V. M., Castro, C. M., Chung, J., Miller, N. C., Ullal, A. V., Castano, M. D., Penson, R. T., Lee, H., Birrer, M. J., & Weissleder, R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315370110 · Cited by 57 · see citing works

Microvesicle Proteomic Profiling of Uterine Liquid Biopsy for Ovarian Cancer Early Detection

Barnabas, G. D., Bahar‐Shany, K., Sapoznik, S., Helpman, L., Kadan, Y., Beiner, M. E., Weitzner, O., Arbib, N., Korach, J., Perri, T., et al. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001362 · Cited by 57 · see citing works

The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings

Chang, C., Wang, H.-C., Liao, Y.-P., Chen, Y., Weng, Y., Yu, M., & Lai, H. (2017) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2018.29.e17 · Cited by 55 · see citing works

Next-Generation Sequencing

Gallo, M. L., Lozy, F., & Bell, D. W. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-43139-0_5 · Cited by 54 · see citing works

A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control Sets

Herzog, C. M. S., Marín, F., Jones, A., Evans, I., Reisel, D., Redl, E., Schreiberhuber, L., Paytubi, S., Pelegrina, B., Carmona, Á., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.00266 · Cited by 53 · see citing works

Detection of Somatic TP53 Mutations in Tampons of Patients With High-Grade Serous Ovarian Cancer

Erickson, B. K., Kinde, I., Dobbin, Z. C., Wang, Y., Martin, J. Y., Alvarez, R. D., Conner, M., Huh, W. K., Roden, R. B. S., Kinzler, K. W., et al. (2014) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000484 · Cited by 53 · see citing works

Early detection of cancer using circulating tumor DNA: biological, physiological and analytical considerations

Bronkhorst, A. J., Ungerer, V., & Holdenrieder, S. (2019) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2019.1700902 · Cited by 54 · see citing works

Sensitivity of cervico‐vaginal cytology in endometrial carcinoma: A systematic review and meta‐analysis

Frias‐Gomez, J., Benavente, Y., Ponce, J., Brunet, J., Ibáñez, R., Peremiquel‐Trillas, P., Baixeras, N., Zanca, A., Piulats, J. M., Aytés, À., et al. (2020) · Cancer Cytopathology · doi:10.1002/cncy.22266 · Cited by 50 · see citing works

Future Screening Prospects for Ovarian Cancer

Žilovič, D., Čiurlienė, R., Sabaliauskaitė, R., & Jarmalaitė, S. (2021) · Cancers · doi:10.3390/cancers13153840 · Cited by 47 · see citing works

Retooling the Pap Smear for Ovarian and Endometrial Cancer Detection

Bakkum-Gamez, J. N., & Dowdy, S. C. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.204933 · Cited by 13 · see citing works

Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers

Wang, Y., Li, L., Douville, C. B., Cohen, J. D., Yen, T., Kinde, I., Sundfelt, K., Kjær, S. K., Hruban, R. H., Shih, I., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aap8793 · Cited by 245 · see citing works

Identification of Somatic Mutations in Papanicolaou Smear DNA and Plasma Circulating Cell-Free DNA for Detection of Endometrial and Epithelial Ovarian Cancers: A Pilot Study

Jiang, X., Li, W., Yang, J., Wang, S., Cao, D., Yu, M. Y., Shen, K., Bai, J., & Gao, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.582546 · Cited by 11 · see citing works

Evaluation of cell-free DNA from papanicolaou smears and peripheral blood to detect endometrial cancer

Wang, Y., Yang, J., & Yu, M. Y. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1570938 · Cited by 1 · see citing works

Pap seeking new challenges

Harjes, U. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0013-8 · Cited by 5 · see citing works